Coles C, Condie A, Chetty U, Steel C M, Evans H J, Prosser J
MRC Human Genetics Unit, Western General Hospital, Edinburgh, Scotland.
Cancer Res. 1992 Oct 1;52(19):5291-8.
We have identified and analyzed 41 mutations in p53 in sporadic breast tumors from 136 unselected breast cancer patients and estimate that approximately 40% of such tumors contain p53 mutations. The frequency of G-T transversions and the incidence of guanosine mutations in the nontranscribed strand of the p53 gene were found to be higher than expected, and we suggest, therefore, that exogenous carcinogens have an etiological role in sporadic breast cancers. Mutations were recorded in 44 codons of the p53 gene, with no obvious mutational hot-spots, although mutations at codons 175, 194, 273, and 280 accounted for 25% of the changes. One germ-line mutation was found in 136 patients and so we conclude that constitutional mutation of p53 may be an uncommon etiological factor in breast cancer.
我们已在136例未经选择的乳腺癌患者的散发性乳腺肿瘤中鉴定并分析了41个p53基因的突变,并估计约40%的此类肿瘤含有p53基因突变。发现p53基因非转录链中G-T颠换的频率和鸟苷突变的发生率高于预期,因此我们认为外源性致癌物在散发性乳腺癌中具有病因学作用。p53基因的44个密码子中记录到了突变,没有明显的突变热点,尽管密码子175、194、273和280处的突变占变化的25%。在136例患者中发现了1个种系突变,因此我们得出结论,p53基因的遗传性突变可能是乳腺癌中一个不常见的病因因素。